Accenture names Matt Prebble to lead UK, Ireland & Africa operations

Published 02/10/2025, 14:06
© Reuters

NEW YORK - Accenture (NYSE:ACN) announced Thursday that Matt Prebble will take over as lead for its UK, Ireland & Africa (UKIA) operations, succeeding Shaheen Sayed who has been appointed to the newly created position of Chief Commercial Officer of Reinvention Services.

Prebble, who currently serves as Data & AI lead for EMEA, will also join Accenture’s Global Management Committee, according to a company press release.

In her new role, Sayed will be responsible for streamlining how Accenture delivers AI-enabled solutions to meet evolving client needs. She will focus on integrating capabilities to drive sustainable growth and long-term client value while maintaining her position on the Global Management Committee.

"Shaheen Sayed’s appointment as Chief Commercial Officer marks a significant step in our mission to drive transformative change for our clients," said Manish Sharma, Chief Services Officer, Reinvention Services at Accenture.

Prior to this appointment, Sayed led Accenture’s UKIA business, overseeing growth, strategy, and performance across these markets. Her career at Accenture spans over two decades, during which she has specialized in enterprise-wide technology transformations across multiple industries including banking, telecommunications, and healthcare.

Prebble has been instrumental in accelerating AI adoption programs and building responsible AI frameworks in his current role as Data & AI lead for Accenture in Europe, working with executives from leading global organizations.

Accenture currently employs approximately 779,000 people serving clients in more than 120 countries, generating annual revenues of $69.7 billion. For deeper insights into Accenture’s financial performance and growth prospects, including exclusive ProTips and comprehensive analysis, visit InvestingPro, where you’ll find detailed research reports and expert recommendations.

In other recent news, Accenture reported stronger-than-expected fourth-quarter 2025 results and provided fiscal year 2026 guidance that Mizuho described as "relatively in-line with investor expectations." Despite this, Mizuho lowered its price target for Accenture to $309, maintaining an Outperform rating. Similarly, RBC Capital reduced its price target to $285, citing mixed guidance for fiscal year 2026. Jefferies also adjusted its price target downward to $250 due to Accenture’s ongoing restructuring efforts in line with its AI-focused strategy, while maintaining a Hold rating. On a more positive note, TD Cowen reiterated its Buy rating with a $295 price target, highlighting consistent demand dynamics and generative AI adoption across Accenture’s operations. In strategic moves, Accenture invested in UK-based insurtech startup Rehuman to enhance customer engagement in the insurance sector using data and AI technology. Financial terms of this investment were not disclosed. These developments reflect Accenture’s active engagement in AI and technology-driven initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.